Back to News
Market Impact: 0.35
IDEXX Laboratories Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
IDEXX Laboratories reported third-quarter 2026 organic revenue growth, higher diagnostic utilization and expanded placements of premium instruments. The company raised its full-year revenue and earnings outlook; the article provides no specific figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
IDXX0.70
More News
- Stocks making the biggest moves midday: Oracle, SpaceX, Tempus AI, Rivian & more
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- Coinbase has been battered over the past month. Morgan Stanley says steer clear